Table 1. Frequently used approaches to transduction in tumors.
Viral vectors | Nonviral vectors | ||||||
---|---|---|---|---|---|---|---|
Features | RV | LV | AV | AAV | liposomal | mRNA | transposon/ transposase |
Structure | ssRNA | ssRNA | dsDNA | ssDNA | |||
Infected cell | dividing cells | dividing and quiescent cells | dividing and quiescent cells | dividing and quiescent cells | dividing and quiescent cells | ||
Integration | Yes | Yes | No | Yes | No | No | poor |
Clinical applications | most widely used now | most widely used nonviral vectors | less been applied but have great potential | ||||
General advantage | higher infection rate | safety, ability to transfer large size gene, less toxicity | |||||
General chanllege | immunogenicity, carcinogenicity, poor target cell specificity, inability to transfer large size genes | low transfection efficiency, poor transgene expression | |||||
Cost of production | costly and laborious | cheap and relatively simple |
AAV, adeno-associated virus vector; AV, adenovirus vector; dsDNA, double-stranded deoxyribonucleic acid; LV, lentiviral vector; mRNA, messenger ribonucleic acid; RV, retroviral vector; ssDNA, single-stranded deoxyribonucleic acid; ssRNA, single-stranded ribonucleic acid.